Fort Pitt Capital Group, LLC Pfizer Inc Transaction History

Fort Pitt Capital Group, LLC

$3.53 Billion
Q3 2024

A detailed history of Fort Pitt Capital Group, LLC transactions in Pfizer Inc stock. As of the latest transaction made, Fort Pitt Capital Group, LLC holds 8,262 shares of PFE stock, worth $212,911. This represents 0.01% of its overall portfolio holdings.

Number of Shares

8,262

Previous 8,272 0.12%

Holding current value

$212,911

Previous $231,000 3.46%

% of portfolio

0.01%

Previous 0.01%

31 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 29, 2024	SELL	$27.7 - $31.39 $277 - $313	-10 Reduced 0.12%	8,262 $239,000
Q2 2024 Jul 26, 2024	SELL	$25.26 - $29.6 $92,982 - $108,957	-3,681 Reduced 30.8%	8,272 $231,000
Q1 2024 Apr 11, 2024	SELL	$25.89 - $29.73 $104,466 - $119,960	-4,035 Reduced 25.24%	11,953 $331,000
Q4 2023 Feb 12, 2024	SELL	$26.13 - $33.94 $6,271 - $8,145	-240 Reduced 1.48%	15,988 $460,000
Q3 2023 Nov 07, 2023	SELL	$32.09 - $37.51 $563,404 - $658,563	-17,557 Reduced 51.97%	16,228 $538,000
Q2 2023 Jul 28, 2023	BUY	$36.12 - $41.79 $306,731 - $354,880	8,492 Added 33.57%	33,785 $1.24 Million
Q1 2023 May 16, 2023	SELL	$39.39 - $51.28 $1.98 Million - $2.58 Million	-50,373 Reduced 66.57%	25,293 $1.03 Million
Q4 2022 Feb 07, 2023	BUY	$41.75 - $54.5 $6,763 - $8,829	162 Added 0.21%	75,666 $3.88 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $965,126 - $1.18 Million	-22,055 Reduced 22.61%	75,504 $3.3 Million
Q2 2022 Jul 20, 2022	SELL	$46.53 - $55.17 $765,837 - $908,043	-16,459 Reduced 14.44%	97,559 $5.12 Million
Q1 2022 May 03, 2022	SELL	$45.75 - $56.69 $909,921 - $1.13 Million	-19,889 Reduced 14.85%	114,018 $5.9 Million
Q4 2021 Feb 02, 2022	SELL	$41.32 - $61.25 $86,648 - $128,441	-2,097 Reduced 1.54%	133,907 $7.91 Million
Q3 2021 Nov 05, 2021	SELL	$39.25 - $50.42 $317,728 - $408,149	-8,095 Reduced 5.62%	136,004 $5.85 Million
Q2 2021 Jul 29, 2021	BUY	$35.91 - $40.68 $21,653 - $24,530	603 Added 0.42%	144,099 $5.64 Million
Q1 2021 Apr 16, 2021	SELL	$33.49 - $37.77 $109,947 - $123,998	-3,283 Reduced 2.24%	143,496 $5.2 Million
Q4 2020 Feb 24, 2021	BUY	$33.47 - $42.56 $4.91 Million - $6.24 Million	146,633 Added 100433.56%	146,779 $5.4 Million
Q4 2020 Feb 23, 2021	SELL	$33.47 - $42.56 $5.43 Million - $6.9 Million	-162,123 Reduced 99.91%	146 $5.4 Million
Q3 2020 Nov 13, 2020	SELL	$31.75 - $37.25 $750,411 - $880,403	-23,635 Reduced 12.71%	162,269 $5.96 Million
Q2 2020 Aug 12, 2020	SELL	$30.12 - $36.54 $325,416 - $394,778	-10,804 Reduced 5.49%	185,904 $6.08 Million
Q1 2020 May 15, 2020	BUY	$27.03 - $38.62 $110,255 - $157,530	4,079 Added 2.12%	196,708 $6.42 Million
Q4 2019 Feb 18, 2020	SELL	$32.92 - $37.36 $201,997 - $229,240	-6,136 Reduced 3.09%	192,629 $7.55 Million
Q3 2019 Nov 14, 2019	BUY	$32.49 - $42.13 $765,626 - $992,793	23,565 Added 13.45%	198,765 $7.14 Million
Q2 2019 Aug 09, 2019	SELL	$36.98 - $41.52 $119,963 - $134,690	-3,244 Reduced 1.82%	175,200 $7.59 Million
Q1 2019 May 09, 2019	SELL	$37.5 - $41.2 $467,925 - $514,093	-12,478 Reduced 6.54%	178,444 $7.58 Million
Q4 2018 Feb 06, 2019	BUY	$38.47 - $43.86 $354,231 - $403,862	9,208 Added 5.07%	190,922 $8.33 Million
Q3 2018 Nov 06, 2018	SELL	$34.47 - $41.81 $29,506 - $35,789	-856 Reduced 0.47%	181,714 $8.01 Million
Q2 2018 Aug 09, 2018	SELL	$32.98 - $35.16 $684,499 - $729,745	-20,755 Reduced 10.21%	182,570 $6.62 Million
Q1 2018 May 14, 2018	BUY	$31.91 - $37.02 $80,126 - $92,957	2,511 Added 1.25%	203,325 $7.22 Million
Q4 2017 Feb 02, 2018	BUY	$33.26 - $35.29 $24,246 - $25,726	729 Added 0.36%	200,814 $7.27 Million
Q3 2017 Oct 26, 2017	SELL	$31.0 - $34.15 $25,327 - $27,900	-817 Reduced 0.41%	200,085 $7.14 Million
Q2 2017 Aug 17, 2017	BUY	N/A	200,902	200,902 $6.75 Million

Others Institutions Holding PFE

# of Institutions

3,258

Shares Held

3.62B

Call Options Held

77.2M

Put Options Held

122M

View Full List

About PFIZER INC

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $145B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

More about PFE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fort Pitt Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fort Pitt Capital Group, LLC with notifications on news.

Account

Fort Pitt Capital Group, LLC Pfizer Inc Transaction History